Immunosuppressant therapy averts rejection of allogeneic FKBP1A-disrupted CAR-T cells.
Maldini CR, Messana AC, Bendet PB, Camblin AJ, Musenge FM, White ML, Rocha JJ, Coholan LJ, Karaca C, Li F, Yan B, Vrbanac VD, Marte E, Claiborne DT, Boutwell CL, Allen TM.
Maldini CR, et al. Among authors: white ml.
Mol Ther. 2024 Oct 2;32(10):3485-3503. doi: 10.1016/j.ymthe.2024.06.022. Epub 2024 Sep 1.
Mol Ther. 2024.
PMID: 39222637
Free PMC article.